Evidence map›Paper›PMID 36017742›Full record

ArticleDisease models & mechanisms2022

Modeling Spitz melanoma in zebrafish using sequential mutagenesis.

Jeffrey K Mito, Margaret C Weber, Alexandra Corbin, George F Murphy, Leonard I Zon

Open access · goldAbstract read
In one paragraph

Article in Disease models & mechanisms, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Sharing resources to advance translational research.Disease models & mechanisms · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Jeffrey K MitoStem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA 02215, USA.ORCID 0000-0002-4016-4494
Margaret C WeberStem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA 02215, USA.
Alexandra CorbinStem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA 02215, USA.ORCID 0000-0002-1759-885X
George F MurphyDepartment of Pathology, Brigham and Women's Hospital, Boston, MA 02215, USA.
Leonard I ZonStem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA 02215, USA.ORCID 0000-0003-0860-926X
Boston Children's Hospital · USBrigham and Women's Hospital · US

Funding

VectorP30CA006516 · NCI · DANA-FARBER CANCER INSTITUTE · PI JENNIFER W MACK · 1985 to 2026
$330.6M
Transcriptional mechanisms and melanomaP01CA163222 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI DAVID E FISHER · 2013 to 2026
$25.3M
VASCULAR, PULMONARY AND RENAL INJURYT32HL007627 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI GIMBRONE, MICHAEL A, MITCHELL, RICHARD N · 1985 to 2019
$12.7M
Cancer Biology in the ZebrafishR01CA103846 · NCI · CHILDREN'S HOSPITAL BOSTON · PI ZON, LEONARD IRA · 2003 to 2022
$7.5M
NCI NIH HHS P01 CA163222NCI NIH HHS P30 CA006516NCI NIH HHS P30 CA06516NCI NIH HHS R01 CA103846NHLBI NIH HHS T32 HL007627
6 · The paper itself

Abstract

Spitz neoplasms are a diverse group of molecularly and histologically defined melanocytic tumors with varying biologic potentials. The precise classification of Spitz neoplasms can be challenging. Recent studies have revealed recurrent fusions involving multiple kinases in a large proportion of Spitz tumors. In this study, we generated a transgenic zebrafish model of Spitz melanoma using a previously identified ZCCHC8-ROS1 fusion gene. Animals developed grossly apparent melanocytic proliferations as early as 3 weeks of age and overt melanoma as early as 5 weeks. By 7 weeks, ZCCHC8-ROS1 induced a histologic spectrum of neoplasms ranging from hyperpigmented patches to melanoma. Given the swift onset of these tumors during development, we extended this approach into adult fish using a recently described electroporation technique. Tissue-specific expression of ZCCHC8-ROS1 in adults led to melanocyte expansion without overt progression to melanoma. Subsequent electroporation with tissue-specific CRISPR, targeting only tp53 was sufficient to induce transformation to melanoma. Our model exhibits the use of sequential mutagenesis in the adult zebrafish, and demonstrates that ZCCHC8-ROS1 induces a spectrum of melanocytic lesions that closely mimics human Spitz neoplasms.

Indexed as

MelanomaNevus, Epithelioid and Spindle CellSkin NeoplasmsAnimalsCutaneous Malignant MelanomaHumansMutagenesisProtein-Tyrosine KinasesProto-Oncogene ProteinsZebrafishProtein-Tyrosine KinasesProto-Oncogene ProteinsCancerElectroporationMelanomaSpitz neoplasmZebrafish

Identifiers

PMID36017742
PMCPMC9438928
OpenAlexW4293199547

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.